Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BLCO – Bausch + Lomb Corporation

BLCO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

9.54

Margin Of Safety %

14

Put/Call OI Ratio

0.1

EPS Next Q Diff

0.19

EPS Last/This Y

EPS This/Next Y

0.29

Price

16.75

Target Price

18.64

Analyst Recom

2.36

Performance Q

Upside

-200.1%

Beta

0.55

Ticker: BLCO




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13BLCO16.240.090.104905
2026-07-14BLCO15.980.090.004933
2026-07-15BLCO16.270.091.004935
2026-07-16BLCO16.80.090.074936
2026-07-17BLCO16.250.090.044993
2026-07-20BLCO15.980.140.032567
2026-07-21BLCO15.980.130.022883
2026-07-22BLCO15.960.120.003062
2026-07-23BLCO160.110.003391
2026-07-24BLCO16.20.110.003395
2026-07-27BLCO16.280.110.003403
2026-07-28BLCO16.530.110.033478
2026-07-29BLCO16.20.100.003581
2026-07-30BLCO16.990.100.013573
2026-07-31BLCO16.910.100.023672
2026-08-03BLCO16.750.100.063712
2026-08-04BLCO16.690.100.183768
2026-08-05BLCO16.740.100.063762
2026-08-07BLCO16.750.100.303742
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13BLCO16.21128.0- 0.80
2026-07-14BLCO15.97128.0- 0.80
2026-07-15BLCO16.29128.0- 0.80
2026-07-16BLCO16.81128.0- 0.80
2026-07-17BLCO16.24128.0- 0.80
2026-07-20BLCO15.99128.0- 0.80
2026-07-21BLCO15.98129.1- 0.80
2026-07-22BLCO15.95129.1- 0.80
2026-07-23BLCO16.00129.1- 0.80
2026-07-24BLCO16.18129.1- 0.80
2026-07-27BLCO16.27129.1- 0.80
2026-07-28BLCO16.60129.1- 0.80
2026-07-29BLCO16.19129.1- 0.80
2026-07-30BLCO16.9821.1- 0.80
2026-07-31BLCO16.9021.1- 0.80
2026-08-03BLCO16.7618.4- 0.80
2026-08-04BLCO16.7618.4- 0.80
2026-08-05BLCO16.7418.4-4.20.80
2026-08-06BLCO16.3418.4-9.00.80
2026-08-07BLCO16.7518.6- 0.80
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




2 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-06BLCO0.02-1.079.54
2026-08-07BLCO0.02-1.079.54
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2 items Current Page1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.21

Avg. EPS Est. Next Quarter

0.35

Insider Transactions

0.02

Institutional Transactions

-1.07

Beta

0.55

Average Sales Estimate Current Quarter

1370

Average Sales Estimate Next Quarter

1487

Fair Value

19.15

Quality Score

56

Growth Score

81

Sentiment Score

45

Actual DrawDown %

23.7

Max Drawdown 5-Year %

Target Price

18.64

P/E

Forward P/E

15.5

PEG

0.38

P/S

1.13

P/B

0.94

P/Free Cash Flow

42.77

EPS

-0.48

Average EPS Est. Cur. Y​

0.8

EPS Next Y. (Est.)

1.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.21

Relative Volume

0.58

Return on Equity vs Sector %

-30

Return on Equity vs Industry %

-12.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

BLCO Healthcare
$16.78
📉
Swing / Pullback
Buy the dip on strong trends
44 /100
WEAK
Trend
0/20
Pullback
8/25
Volume
11/15
Valuation
16/20
TP/AR
1/10
Options
8/10
RSI
55.8
Range 1M
65.9%
Sup Dist
3.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
2/25
Growth
14/30
Estimates
4/20
Inst/Vol
0/15
Options
8/10
EPS Yr
54.7%
52W%
57.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +70.2% upside
Quality
5/30
Valuation
20/30
Growth
10/25
Stability
3/10
LT Trend
1/5
Upside
+70.2%
Quality
56
MoS
14%
BLCO — P/E HistoricalMedical Instruments & Supplies
Bausch + Lomb Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 13000
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
BLCO

Latest News

Caricamento notizie per BLCO
stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today
news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance
stock history BLCO – Bausch + Lomb Corporation invest stock market
stock prices BLCO premarket after hours
ticker BLCO fair value insiders trading